Molecular characterization of the capsule locus from non-typeable Staphylococcus aureus

被引:64
作者
Cocchiaro, JL
Gomez, MI
Risley, A
Solinga, R
Sordelli, DO
Lee, JC [1 ]
机构
[1] Harvard Univ, Sch Med, Channing Lab, Brigham & Womens Hosp,Dept Med, Boston, MA 02115 USA
[2] Univ Buenos Aires, Fac Med, Dept Microbiol, Buenos Aires, DF, Argentina
关键词
D O I
10.1111/j.1365-2958.2005.04978.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Most Staphylococcus aureus express a serotype 5 or 8 capsular polysaccharide (CP). However, 20-25% of human isolates and up to 86% of bovine strains of S. aureus are non-typeable (NT), i.e. non-reactive with antibodies to CP types 1, 2, 5 or 8. A vaccine that targets the S. aureus CP would not protect against NT strains. The aim of this study was to characterize NT S. aureus isolates at the molecular level to explain their lack of type 5 or 8 capsule production. The cap5(8) locus was present in all 22 NT clinical isolates from humans, eight of 21 bovine isolates, and in all eight sequenced strains. NT strains positive for the cap5(8) transcript had mutations within essential capsule genes and could be complemented in trans. S. aureus strains with reduced cap5(8) transcript had mutations within the cap5A promoter, decreased RNAIII levels, or a truncated arlR gene product. More than one mutation was identified in several isolates. The cap5(8) locus was replaced by IS257 in 13 of 21 NT bovine isolates of S. aureus. Lack of capsule expression in NT S. aureus can be explained by multiple mechanisms, and the data argue against the existence of capsule serotypes other than 1, 2, 5 and 8.
引用
收藏
页码:948 / 960
页数:13
相关论文
共 63 条
[1]   PREDOMINANCE OF 2 NEWLY DESCRIBED CAPSULAR POLYSACCHARIDE TYPES AMONG CLINICAL ISOLATES OF STAPHYLOCOCCUS-AUREUS [J].
ARBEIT, RD ;
KARAKAWA, WW ;
VANN, WF ;
ROBBINS, JB .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1984, 2 (02) :85-91
[2]  
AUGUSTIN J, 1990, FEMS MICROBIOL LETT, V66, P203, DOI 10.1016/0378-1097(90)90283-V
[3]   Genome and virulence determinants of high virulence community-acquired MRSA [J].
Baba, T ;
Takeuchi, F ;
Kuroda, M ;
Yuzawa, H ;
Aoki, K ;
Oguchi, A ;
Nagai, Y ;
Iwama, N ;
Asano, K ;
Naimi, T ;
Kuroda, H ;
Cui, L ;
Yamamoto, K ;
Hiramatsu, K .
LANCET, 2002, 359 (9320) :1819-1827
[4]   STAPHYLOCOCCUS-AUREUS MICROCAPSULE EXPRESSION ATTENUATES BACTERIAL VIRULENCE IN A RAT MODEL OF EXPERIMENTAL ENDOCARDITIS [J].
BADDOUR, LM ;
LOWRANCE, C ;
ALBUS, A ;
LOWRANCE, JH ;
ANDERSON, SK ;
LEE, JC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (04) :749-753
[5]   IS431, A STAPHYLOCOCCAL INSERTION SEQUENCE-LIKE ELEMENT RELATED TO IS26 FROM PROTEUS-VULGARIS [J].
BARBERISMAINO, L ;
BERGERBACHI, B ;
WEBER, H ;
BECK, WD ;
KAYSER, FH .
GENE, 1987, 59 (01) :107-113
[6]   Genotypic analysis of Staphylococcus aureus from milk of dairy cows with mastitis in Argentina [J].
Buzzola, FR ;
Quelle, L ;
Gomez, MI ;
Catalano, M ;
Steele-Moore, L ;
Berg, D ;
Gentilini, E ;
Denamiel, G ;
Sordelli, DO .
EPIDEMIOLOGY AND INFECTION, 2001, 126 (03) :445-452
[7]   FlaA1, a new bifunctional UDP-GlcNAc C6 dehydratase C4 reductase from Helicobacter pylori [J].
Creuzenet, C ;
Schur, MJ ;
Lin, JJ ;
Wakarchuk, WW ;
Lam, JS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (45) :34873-34880
[8]   Capsule production and growth phase influence binding of complement to Staphylococcus aureus [J].
Cunnion, KM ;
Lee, JC ;
Frank, MM .
INFECTION AND IMMUNITY, 2001, 69 (11) :6796-6803
[9]   INVOLVEMENT OF THE ACCESSORY GENE REGULATOR (AGR) IN EXPRESSION OF TYPE-5 CAPSULAR POLYSACCHARIDE BY STAPHYLOCOCCUS-AUREUS [J].
DASSY, B ;
HOGAN, T ;
FOSTER, TJ ;
FOURNIER, JM .
JOURNAL OF GENERAL MICROBIOLOGY, 1993, 139 :1301-1306
[10]   Genetic basis for nongroupable Neisseria meningitidis [J].
Dolan-Livengood, JM ;
Miller, YK ;
Martin, LE ;
Urwin, R ;
Stephens, DS .
JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (10) :1616-1628